Mattingly, T. Joseph II https://orcid.org/0000-0001-7786-5780
Article History
Accepted: 14 November 2023
First Online: 12 December 2023
Declarations
:
: No funding was received for the preparation of this article.
: T. Joseph Mattingly II discloses unrelated research funding from the US Food and Drug Administration, National Institute on Minority Health and Health Disparities, the ALSAM Foundation, and the Alzheimer’s Association. He also discloses unrelated consulting fees received in the past 24 months from the Pharmaceutical Research and Manufacturers of America and Arnold Ventures.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All aspects of the manuscript were developed and are the sole opinions of the author (TJM).